Their study results showed a trend but insignificant of lower mortality risk in gastric cancer (adjusted HR = 0.79, 95%CI = 0.62–1.00) than esophageal cancer (adjusted HR = 0.89, 95%CI = 0.71–1.10).
← all excerpts
Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
1
—
—